These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21134344)

  • 1. Effects of montelukast on burn wound healing in a rat model.
    Turtay MG; Firat C; Samdanci E; Oguzturk H; Erbatur S; Colak C
    Clin Invest Med; 2010 Dec; 33(6):E413-21. PubMed ID: 21134344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montelukast, an Antagonist of Cysteinyl Leukotriene Signaling, Impairs Burn Wound Healing.
    Nguyen AV; Bagood MD; Wang M; Caryotakis SE; Smith G; Yee S; Shen H; Isseroff RR; Soulika AM
    Plast Reconstr Surg; 2022 Jul; 150(1):92e-104e. PubMed ID: 35536768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant activity of histamine and cysteinyl leukotrienes on porcine nasal mucosal vessels and nasal inflammation in the rat.
    Lieber G; Jimenez J; Hunter JC; McLeod RL; Jia Y
    Pharmacology; 2010; 85(5):311-8. PubMed ID: 20453555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury.
    Erşahin M; Çevik Ö; Akakın D; Şener A; Özbay L; Yegen BC; Şener G
    Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):131-9. PubMed ID: 22986158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathologic evaluation of anti-ulcerogenic effect of montelukast in indomethacin-induced experimental ulcer model.
    Ozbakış-Dengiz G; Cadırcı E; Yurdakan G
    Turk J Gastroenterol; 2013; 24(2):88-92. PubMed ID: 23934453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs.
    Sener G; Kabasakal L; Cetinel S; Contuk G; Gedik N; Yeğen BC
    Burns; 2005 Aug; 31(5):587-96. PubMed ID: 15935562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic potential of montelukast against mild colitis induced by dextran sulphate sodium in rats.
    Holma R; Salmenperä P; Virtanen I; Vapaatalo H; Korpela R
    J Physiol Pharmacol; 2007 Sep; 58(3):455-67. PubMed ID: 17928642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Montelukast attenuates neuropathic pain through inhibiting p38 mitogen-activated protein kinase and nuclear factor-kappa B in a rat model of chronic constriction injury.
    Zhou C; Shi X; Huang H; Zhu Y; Wu Y
    Anesth Analg; 2014 May; 118(5):1090-6. PubMed ID: 24686047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of leukotriene inhibitor montelukast on wound contraction and cutaneous healing process in rats.
    Tolazzi AR; Tolazzi KD; Garcia M; Graf RM; Freitas RS; Baretta GA; Matias JE; Campos AC
    Aesthetic Plast Surg; 2009 Jan; 33(1):84-9. PubMed ID: 18797959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Montelukast protects axial pattern rat skin flaps against ischemia/reperfusion injury.
    Gideroglu K; Yilmaz F; Aksoy F; Bugdayci G; Saglam I; Yimaz F
    J Surg Res; 2009 Dec; 157(2):181-6. PubMed ID: 19589545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Otostegia persica extraction on healing process of burn wounds.
    Ganjali A; Sotoudeh A; Jahanshahi A; Takhtfooladi MA; Bazzazan A; Roodbari N; Harati MP
    Acta Cir Bras; 2013 Jun; 28(6):407-11. PubMed ID: 23743676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects montelukast, cysteinyl-leukotriene receptor antagonist, on renal damage after unilateral ureteral obstruction in rats.
    Otunctemur A; Ozbek E; Cakir SS; Dursun M; Cekmen M; Polat EC; Ozcan L; Somay A; Ozbay N
    Int Braz J Urol; 2015; 41(2):279-87. PubMed ID: 26005969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteinyl-leukotriene receptor antagonist montelukast decreases blood-brain barrier permeability but does not prevent oedema formation in traumatic brain injury.
    Biber N; Toklu HZ; Solakoglu S; Gultomruk M; Hakan T; Berkman Z; Dulger FG
    Brain Inj; 2009 Jun; 23(6):577-84. PubMed ID: 19484631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of montelukast on the healing of ischemic colon anastomoses.
    Celik A; Ergun E; Koksal N; Celik AS; Altinli E; Uzun MA; Eroglu E; Kemik A
    Am J Surg; 2013 Oct; 206(4):502-8. PubMed ID: 23809995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Glucan treatment prevents progressive burn ischaemia in the zone of stasis and improves burn healing: an experimental study in rats.
    Firat C; Samdanci E; Erbatur S; Aytekin AH; Ak M; Turtay MG; Coban YK
    Burns; 2013 Feb; 39(1):105-12. PubMed ID: 22469518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukotriene D4 inhalation challenge for predicting short-term efficacy of montelukast: a pilot study.
    Guan WJ; Shi X; Zheng JP; Gao Y; Jiang CY; Xie YQ; Liu QX; Zhu Z; Guo E; An JY; Yu XX; Liu WT; Zhong NS
    Clin Respir J; 2015 Jan; 9(1):111-20. PubMed ID: 24506412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of montelukast which is cysteinyl-leukotriene receptor antagonist on gentamicin-induced nephrotoxicity and oxidative damage in rat kidney.
    Otunctemur A; Ozbek E; Cekmen M; Cakir SS; Dursun M; Polat EC; Somay A; Ozbay N
    Ren Fail; 2013; 35(3):403-10. PubMed ID: 23342977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
    Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
    Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burn-induced oxidative injury of the gut is ameliorated by the leukotriene receptor blocker montelukast.
    Kabasakal L; Sener G; Cetinel S; Contuk G; Gedik N; Yeğen BC
    Prostaglandins Leukot Essent Fatty Acids; 2005 Jun; 72(6):431-40. PubMed ID: 15890506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.